SCIENTISTS working in the United States and Brazil have released new research data announcing a breakthrough in the treatment of type one diabetes.
15/04/2009
THE SCLERODERMA Foundation says scleroderma is an autoimmune disease which leads to thickening and severe scarring of skin as well as thickening and failure of internal organs affecting approximately 300,000 Americans.
13/03/2009
RESEARCHERS from DaVinci Biosciences, in collaboration with Hospital Luis Vernaza in Ecuador, have determined that injecting a patient's own bone marrow-derived stem cells (BMCs) directly into the spinal column using multiple routes can be an effective treatment for spinal cord injury, returning some quality of life for patients without serious adverse events.
17/03/2009
The US Food and Drug Administration (FDA) has approved Rituxan/MabThera (rituximab) plus fludarabine and cyclophosphamide (FC) chemotherapy for people with either previously untreated (first-line) or previously treated (relapsed or refractory) CD20-positive chronic lymphocytic leukemia (CLL).
22/02/2010
MESOBLAST has announced that it has successfully implanted the first five bone marrow transplant patients as part of its Phase I/II trial.
25/06/2009
GE has launched a ‘GE Healthymagination Fund’ that will invest in highly promising healthcare technology companies. The equity fund will focus on companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the strategic objectives of GE’s Healthymagination initiative.
23/10/2009